x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Xtalks Life Science Podcast

This Life Science focused podcast brings together Xtalks editorial staff to share insights into the latest B2B industry news. Xtalks connects professionals in the life science, medical device, and food industries with useful content like webinars, job opening, articles and virtual meetings.

science life sciences

All Episodes

37:02

Off the Shelf Cell Therapies for Bone Marrow...

Xtalks Life Science Podcast ·

2026/04/15

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Kevin Caldwell, CEO, Co-Founder & President of Ossium Health, a biotechnology company advancing the first off-the-shelf bone marrow therapy derived from deceased organ donors. The treatment is designed to address longstanding clinical and logistical challenges in allogeneic bone marrow transplantation.Kevin Caldwell has led Ossium Health in building more than 50

en-us

28:30

Scalable Biologics Production Trends: Featuring Omar...

Xtalks Life Science Podcast ·

2026/04/08

In this episode of the Xtalks Life Science Podcast, part of the Breakthrough with Dr. Corey Stanton series, host Dr. Corey Stanton sits down with Dr. Omar Wahab, Vice President of Bioprocessing at Lonza, to explore the increasingly strategic role of cell culture media in enabling scalable biologics manufacturing.As biologics pipelines continue to expand across therapeutic areas such as oncology, immunology and advanced therapies, upstream development decisions are taking on new importance in

en-us

40:04

Novel Therapeutic and Trial Approaches for Lysosomal...

Xtalks Life Science Podcast ·

2026/04/01

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Alex Yang, JD, LLM, CEO of Polaryx, a company focused on developing disease-modifying small molecule therapies for rare, pediatric lysosomal storage disorders.Alex is a biotech executive and investor with over 25 years of experience spanning law, private equity, cross-border fund formation and strategic leadership across the biopharmaceutical sector. He currently

en-us

21:33

Psilocybin Treatments for Treatment-Resistant...

Xtalks Life Science Podcast ·

2026/03/25

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Steve Levine, MD, Chief Patient Officer at Compass Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health.One of the areas that Compass Pathways is working in is the development of psilocybin-based treatments for treatment-resistant depression (TRD). Dr. Levine is a board-certified psychiatrist who has

en-us

39:02

First Surrogate Endpoint in Osteoporosis Drug Trials...

Xtalks Life Science Podcast ·

2026/03/18

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Tania Nayak Kamphaus, PhD, Associate VP of Science Partnerships at the Foundation for the National Institutes of Health (FNIH).In December 2025, the FDA qualified bone density DXA scans as the first surrogate endpoint for bone fractures in clinical trials of anti-osteoporosis drugs in post-menopausal women at risk for osteoporosis fracture. The surrogate endpoint will

en-us

43:01

From Insights to Impact: Rare Disease Therapies with...

Xtalks Life Science Podcast ·

2026/03/11

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Kim Moran, PhD, Senior Vice President & Head, Rare Diseases US, UCB, a company focused on neurological and immune-mediated inflammatory diseases, as well as developing therapies for rare genetic disorders such as the mitochondrial disease thymidine kinase 2 deficiency (TK2d).Dr. Moran has been at UCB for over 17 years where she has led US digital business

en-us

36:40

Rare Disease Day Insight: Epilepsy Care Gaps in...

Xtalks Life Science Podcast ·

2026/03/04

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Andrea Wilkinson, Global Head of Patient Engagement & Advocacy, Epilepsy & Neuromuscular at UCB, a company dedicated to developing solutions for autoimmune and neurological conditions, including epilepsy. The company has a growing commitment to addressing unmet needs in rare neurological diseases and underserved patient populations.With fewer than 5% of

en-us

34:05

Anti-Aging Gene Therapy in Alzheimer’s and ALS with...

Xtalks Life Science Podcast ·

2026/02/18

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Joseph Sinkule, CEO, Founder and the Chairman of the Board of Directors at Klotho Neurosciences, a biogenetics company developing cell and gene therapies using a patented, secreted form of the “anti-aging” human α-Klotho gene for the treatment of neurodegenerative, age-related disorders such as Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s

en-us

47:27

Translating Nerve Growth Factor Biology into Ocular...

Xtalks Life Science Podcast ·

2026/02/04

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Ahmed Enayetallah, PhD, MBBCh, Chief Development Officer at Dompé Farmaceutici, a company founded as the first compounding pharmacy in Milan, Italy, which has grown into a global biopharmaceutical company over 130 years.Currently, the company has a therapeutic pipeline focused on nerve growth factor (NGF)-based therapeutics in ocular diseases, including non-arteritic

en-us

36:42

Innovative Approaches to Regenerative Therapies in...

Xtalks Life Science Podcast ·

2026/01/28

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Jason Matuszewski, chairman, CEO and co-founder of BioStem Technologies, a company developing perinatal tissue allografts for regenerative therapies.The applications of the allografts, developed using the company’s proprietary processing method, include wound care, limb saving in conditions like diabetic foot ulcers and treating wounds and amputations of

en-us

28:18

Fostering Collaboration to Accelerate Drug Discovery...

Xtalks Life Science Podcast ·

2026/01/27

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Michelle Hoffmann, PhD, Executive Director of the Chicago Biomedical Consortium (CBC). CBC is a consortium of biomedical researchers across Northwestern University, the University of Illinois at Chicago and the University of Chicago supported by the Searle Funds at The Chicago Community Trust. The CBC’s mission is to stimulate collaboration among scientists to

en-us

51:59

Fostering Collaboration to Accelerate Drug Discovery...

Xtalks Life Science Podcast ·

2026/01/14

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Michelle Hoffmann, PhD, Executive Director of the Chicago Biomedical Consortium (CBC).CBC is a consortium of biomedical researchers across Northwestern University, the University of Illinois at Chicago and the University of Chicago supported by the Searle Funds at The Chicago Community Trust. The CBC’s mission is to stimulate collaboration among scientists to

en-us

36:39

Targeting Inflammation in Eye Diseases with Iolyx...

Xtalks Life Science Podcast ·

2026/01/07

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Elizabeth Jeffords, CEO, Iolyx Therapeutics, which is developing targeted therapies to address inflammation in ocular disease.Elizabeth is a seasoned biotech leader with experience spanning company building, fundraising, clinical development, major product launches and a >$9 billion global P&L. Before Iolyx, she served as Chief Commercial & Strategy Officer

en-us

47:01

Pioneering Biosensors for Continuous Medical...

Xtalks Life Science Podcast ·

2025/12/10

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Ben Hwang, PhD, Chairman and CEO of Profusa, Inc., a company developing a platform of new generation bioengineered, biointegrated sensors for the real-time, continuous monitoring of body chemistry for chronic disease management and health.The sensors detect and continuously transmit medical-grade data for personal and medical use. Dr. Hwang has served as Profusa’s

en-us

32:53

The Biology of Aging: Innovations in Cellular...

Xtalks Life Science Podcast ·

2025/12/03

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Sharon Rosenzweig-Lipson, PhD, Chief Scientific Officer (CSO) at Life Biosciences, a company advancing cellular rejuvenation gene therapies to treat age-related diseases.The company is targeting eye diseases like glaucoma and non-arteritic anterior ischemic optic neuropathy (NAION). Dr. Rosenzweig-Lipson has held leadership positions in both big pharma and small

en-us

38:33

The Evolving Landscape of Respiratory and Immunology...

Xtalks Life Science Podcast ·

2025/11/26

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Andrew Menzies-Gow, MBBS, PhD, Vice President Respiratory & Immunology, Global Biopharmaceuticals Medical, AstraZeneca, about innovations in respiratory and immunology drug development.Dr. Menzies-Gow is an expert in respiratory biologics and severe asthma research with a prolific career in respiratory medicine, combining his background as a practicing clinician

en-us

30:35

Restoring Lost Synapses in ALS, Fragile X and More...

Xtalks Life Science Podcast ·

2025/11/19

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Peter Vanderklish, PhD, chief scientific officer at Spinogenix, a company developing therapeutics aimed at restoring synaptic connections for conditions such as ALS, Alzheimer’s disease, schizophrenia and Fragile X syndrome.Dr. Vanderklish’s decades of research, from his graduate work at UC Irvine to his roles at The Scripps Research Institute and UC Irvine, have

en-us

39:54

Targeting Protein Misfolding and Innovations in...

Xtalks Life Science Podcast ·

2025/11/11

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Pol Boudes, MD, Chief Medical Officer at Rectify Pharma.Rectify Pharma is a biotechnology company pioneering a positive functional modulators (PFM) platform to address the root causes of genetic and protein folding diseases in the liver, cardio-renal-metabolic and neurodegenerative spaces. The company’s lead program is in hepatobiliary diseases. Dr. Boudes has more

en-us

35:55

Advancing Rare Disease Treatment and Care with...

Xtalks Life Science Podcast ·

2025/11/05

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Mike Denne, PharmD, Vice President of US Medical Affairs for Rare Disease and Plasma Derived Therapies at Takeda, to discuss the company’s approach to advancing patient care in the area of rare diseases through medical innovation and collaboration.With over 15 years of leadership experience in medical affairs, Dr. Denne shares his insights on building effective and

en-us

31:57

Advancing Gene Therapies for Diabetes and...

Xtalks Life Science Podcast ·

2025/10/29

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks.com, welcomes Mike Exton, PhD, CEO of Lexicon Pharmaceuticals, for a conversation about leveraging gene science to develop innovative medicines for serious chronic conditions.Dr. Exton discusses Lexicon’s growing pipeline, which includes promising therapies for diabetic peripheral neuropathic pain, hypertrophic cardiomyopathy and other cardiometabolic diseases, areas where unmet

en-us

248 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter